Only 9 Pfizer C-19 lots met "interchangeable" FDA approved criteria!

There were only 9 out of thousands of lots of the Pfizer BioNtech vaccine that were considered "equivalent" to the FDA approved version according to Pfizer documentation. An individuals chances of receiving the "equivalent" version was approximately 1%. People lost their jobs because businesses were led to believe that all of the EUA product in the US was equivalent but that wasn't the case as Pfizer clearly stated in a letter addressed to healthcare professionals.